Skip to main content
Clinical Trials/CTRI/2018/09/015797
CTRI/2018/09/015797
Not Yet Recruiting
Phase 2

EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN CASES OF WRIST GANGLION : A PROSPECTIVE, PARALLEL ARM, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIA

Central Council for Research in Homoeopathy0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: M674- Ganglion
Sponsor
Central Council for Research in Homoeopathy
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient having wrist ganglion (diagnosed clinically and by USG) for the duration of 6 months or less.
  • 2\. Age 18 years and above.
  • 3\. Gender: Both Male and Female.
  • 4\. Willing to give informed consent to participate in the study.
  • 5\. Patient must not be under any treatment for wrist ganglion at\-least for last one month. (If under previous treatment within last one month, washout period will be allowed for one month from the last date of intake of previous medicine.)

Exclusion Criteria

  • 1\. Patients who are immune\-compromised and/or suffering from critical illness.
  • 2\. Patients who are severely drug/alcohol addicted.
  • 3\. Patients unable or unwilling to give informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials